StockNews.com Initiates Coverage on Aptose Biosciences (NASDAQ:APTO)

Research analysts at StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. APTO has been the subject of several other research reports. Canaccord Genuity Group reduced their price target on […]

Leave a Reply

Your email address will not be published.

Previous post Shinhan Financial Group (NYSE:SHG) Downgraded to Hold at StockNews.com
Next post FY2024 EPS Estimates for AutoZone, Inc. Decreased by Analyst (NYSE:AZO)